A fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)
A fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)
For Primary Dysbetalipoproteinemia (Type III hyperlipidemia) that does not respond adequately to diet. This helps control high cholesterol and high triglyceride levels.
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
1999/10/28 | Phase 3 | Completed | |||
1999/10/28 | Not Applicable | Completed |
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. | Online |
---|
No Singapore products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
Clofibrate Capsules | 国药准字H11020973 | 华润双鹤药业股份有限公司 | N/A | N/A | 0.5g | Chemical Drug | Approved | 2010/08/10 | Domestic |
Clofibrate Capsules | 国药准字H21020479 | 沈阳同联药业有限公司 | N/A | N/A | 0.25g | Chemical Drug | Approved | 2010/08/30 | Domestic |
Clofibrate Capsules | 国药准字H21020442 | 沈阳同联药业有限公司 | N/A | N/A | 0.5g | Chemical Drug | Approved | 2010/08/30 | Domestic |
Clofibrate Capsules | 国药准字H13022306 | 河北天成药业股份有限公司 | 胶囊剂 | N/A | 0.5g | Chemical Drug | Approved | 2002/08/16 | Domestic |
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|---|---|---|---|---|
COL Capsules | 27891 | Alphapharm Pty Ltd | Active | 1991/10/21 | clofibrate |